Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases. | Hum Mutat | 2026 | 41756679 | PubTator, text mining | PubMed |
| Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. | Research (Wash D C) | 2026 | 41743623 | PubTator, text mining | PubMed |
| Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia. | Ann Hematol | 2026 | 41739208 | PubTator, text mining | PubMed |
| Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer. | J Natl Cancer Cent | 2026 | 41738039 | PubTator, text mining | PubMed |
| Genetic and epigenetic mechanisms underlying treatment-induced neuroendocrine prostate cancer. | J Natl Cancer Cent | 2026 | 41738035 | PubTator, text mining | PubMed |
| Modeling mitochondrial inheritance enables high-precision single-cell lineage tracing in humans. | bioRxiv | 2026 | 41726901 | PubTator, text mining | PubMed |
| Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancer. | Neoplasia | 2026 | 41720070 | PubTator, text mining | PubMed |
| Pathogenesis and intervention strategies for metabolic dysfunction-associated fatty liver disease from the perspective of the gut-microbiota-liver axis. | Front Immunol | 2026 | 41716420 | PubTator, text mining | PubMed |
| MacroH2A-Mediated Gene Repression through Nucleosome Compaction and Remodeling Inhibition. | bioRxiv | 2026 | 41659497 | PubTator, text mining | PubMed |
| Exploring the biology of metastatic hormone-sensitive prostate cancer: on the road to precision medicine. | J Clin Invest | 2026 | 41623173 | PubTator, text mining | PubMed |
| GPR176 enhances the epithelial‑mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway. | Oncol Rep | 2026 | 41574720 | PubTator, text mining | PubMed |
| CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance. | Cell Rep Med | 2026 | 41564866 | PubTator, text mining | PubMed |
| Genotype subtyping approach to identify unnoticed variants in diseases from GWAS data. | BioData Min | 2026 | 41519843 | PubTator, text mining | PubMed |
| Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma. | Drug Resist Updat | 2026 | 41297453 | PubTator, text mining | PubMed |
| Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer. | Eur Urol | 2026 | 40774853 | PubTator, text mining | PubMed |
| The role of microrna-346 in prostate cancer progression: Clinical significance and biomarker potential. | J Med Biochem | 2025 | 41799178 | PubTator, text mining | PubMed |
| Comprehensive and In-Depth Molecular and Pathway Studies of the Hippocampus in Alzheimer's Disease. | Cell Mol Neurobiol | 2025 | 41317176 | PubTator, text mining | PubMed |
| Cross-Species Validation of Pigeon-Specific CHD1 Primers for Molecular Sexing in Pet Birds. | Int J Mol Sci | 2025 | 41303624 | PubTator, text mining | PubMed |
| Distinct functional heterogeneity of TP53 R175 mutations in platinum-resistant ovarian cancer: unveiling molecular mechanisms and therapeutic targets. | Cell Death Dis | 2025 | 41249788 | PubTator, text mining | PubMed |
| Condensation-dependent interactome of a chromatin remodeler underlies tumor suppressor activities. | Nat Commun | 2025 | 41168190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=2